---
schema_version: "secwatch.filing_event.v1"
accession: "0001641172-25-015695"
form_type: "8-K"
ticker: "PVCT"
cik: "0000315545"
company_name: "PROVECTUS BIOPHARMACEUTICALS, INC."
filed_at: "2025-06-20T23:59:59+00:00"
generated_at: "2026-05-19T02:05:37.814222+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Provectus shareholders approve reverse stock split authorization and elect directors at annual meeting

## Summary
- Stockholders elected all four director nominees: Bailey, Lacey, Pershing, Rodrigues, with >200M votes for each.
- Advisory say-on-pay approved: 195.7M for, 15.1M against, 0.4M abstentions; 138.8M broker non-votes.
- Ratified CBIZ CPAs P.C. as independent auditor for 2025: 337.9M for, 6.2M against, 5.8M abstentions.
- Authorized board to implement reverse stock split at ratio between 1:10 and 1:50; 326.8M for, 18.2M against.
- Authorized reduction in authorized shares by same reverse split ratio; 330.5M for, 16.8M against.

## SEC filing metadata
- accession: 0001641172-25-015695
- form_type: 8-K
- ticker: PVCT
- cik: 0000315545
- company_name: PROVECTUS BIOPHARMACEUTICALS, INC.
- filed_at: 2025-06-20T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/315545/000164117225015695/0001641172-25-015695-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/315545/000164117225015695/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641172-25-015695
- JSON: https://secwatch.observer/filing/0001641172-25-015695.json
- Plain text: https://secwatch.observer/filing/0001641172-25-015695.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.